Novartis had sought to overturn a clause in Indian Patents Law that restricts patent protection for newer forms of existing molecules. The case started in 1997 when Novartis filed a plea for a patent for Glivec...April 1, 2013: Supreme Court rejects Novartis’ plea for patent.